(Q38947587)
Statements
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice (English)
Barbara Renga
Sabrina Cipriani
Daniela Francisci
Andrea Mencarelli
Elisabetta Schiaroli
Franco Baldelli
Stefano Fiorucci